John Oxford

Q: What Schools Are Affiliated With John Oxford

John Oxford is affiliated with the following schools: Imperial College London, University of Oxford, Queen Mary University of London, University of Reading

John Oxford's AcademicInfluence.com Rankings

John Oxford

Biology

#2599

World Rank

#4101

Historical Rank

Virology

#49

World Rank

#51

Historical Rank

biology Degrees

Download Badge

Biology

John Oxford's Degrees

Bachelors Microbiology University of Oxford

Why Is John Oxford Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John Sydney Oxford is an English virologist and a professor at Queen Mary, University of London. He is a leading expert on influenza, including bird flu and the 1918 Spanish Influenza, and HIV/AIDS.

(See a Problem?)

John Oxford's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans (2012) (853)
Oxford (1968) (736)
Determinants of immunity to influenza infection in man. (1979) (466)
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. (2002) (382)
Evidence for host-cell selection of influenza virus antigenic variants (1983) (310)
The burden of influenza B: a structured literature review. (2013) (292)
Viral load drives disease in humans experimentally infected with respiratory syncytial virus. (2010) (275)
Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans (2012) (247)
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. (1987) (208)
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. (2003) (196)
Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. (2002) (177)
An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. (1994) (163)
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. (2009) (148)
1918 Influenza Pandemic and Highly Conserved Viruses with Two Receptor-Binding Variants (2003) (140)
World War I may have allowed the emergence of "Spanish" influenza. (2002) (132)
The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. (2003) (110)
A hypothesis: the conjunction of soldiers, gas, pigs, ducks, geese and horses in northern France during the Great War provided the conditions for the emergence of the "Spanish" influenza pandemic of 1918-1919. (2005) (109)
Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. (2002) (107)
Animal models in influenza vaccine testing (2008) (91)
Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells (1977) (89)
A plant‐produced influenza subunit vaccine protects ferrets against virus challenge (2008) (84)
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. (1969) (83)
Antiviral activity of amantadine: a review of laboratory and clinical data. (1980) (76)
In vivo Selection of an Influenza A2 Strain resistant to Amantadine (1970) (76)
Studies on the mechanism of influenza virus entry into cells. (1979) (75)
Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. (1989) (74)
Negative strand viruses (1976) (74)
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine (2009) (73)
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection (1979) (73)
Antigenic and sequence analysis of H3 influenza virus haemagglutinins from pigs in Italy. (1994) (69)
Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). (1975) (68)
Potential role of human challenge studies for investigation of influenza transmission. (2011) (67)
Immunity to influenza in ferrets. I. Response to live and killed virus. (1972) (66)
Antiretroviral therapy for HIV-2 infected patients. (2001) (62)
Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK). (1987) (62)
Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence (1978) (61)
Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment. (1969) (60)
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. (2011) (58)
A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans (2015) (56)
Meeting Report: Risk Assessment of Tamiflu Use Under Pandemic Conditions (2008) (54)
Comparing Influenza and Rsv Viral and Disease Dynamics in Experimentally Infected Adults Predicts Clinical Effectiveness of Rsv Antivirals (2013) (53)
Immunological and physicochemical studies of influenza matrix (M) polypeptides. (1976) (53)
Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents. (1974) (52)
Evidence for antigenic variation in influenza A nucleoprotein. (1979) (51)
Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody (1981) (49)
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. (1974) (48)
Prescriber and Patient Responsibilities in Treatment of Acute Respiratory Tract Infections — Essential for Conservation of Antibiotics (2013) (47)
Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model. (2014) (47)
Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine. (2004) (46)
The intracellular distribution of influenza virus matrix protein and nucleoprotein in infected cells and their relationship to haemagglutinin in the plasma membrane. (1988) (44)
Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition. (1991) (44)
The so-called Great Spanish Influenza Pandemic of 1918 may have originated in France in 1916. (2001) (42)
Quantitative analysis of the protein composition of influenza A and B viruses using high resolution SDS polyacrylamide gels. (1981) (42)
The survival of influenza A(H1N1)pdm09 virus on 4 household surfaces. (2014) (42)
Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. (2006) (41)
Naturally occurring temperature-sensitive influenza A viruses of the H1N1 and H3N2 subtypes. (1980) (41)
Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit. (1989) (40)
Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920. (2003) (39)
Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis (1982) (38)
Human microbial challenge: the ultimate animal model. (2012) (38)
Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. (1971) (38)
A Throat Lozenge Containing Amyl Meta Cresol and Dichlorobenzyl Alcohol Has a Direct Virucidal Effect on Respiratory Syncytial Virus, Influenza a and SARS-CoV (2005) (37)
Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection (1981) (37)
Detection of two antigenic subpopulations of A(H1N1) influenza viruses from pigs: Antigenic drift or interspecies transmission? (1991) (35)
Developments in antiviral therapy (1980) (35)
Comparison of Transformation and T Antigen Induction in Human Cell Lines (1970) (34)
Scientific lessons from the first influenza pandemic of the 20th century. (2006) (34)
Antigenic and biochemical analysis of field isolates of influenza B virus: evidence for intra- and inter-epidemic variation. (1983) (33)
Antivirals for the treatment and prevention of epidemic and pandemic influenza (2007) (33)
The Determinants of Reported Personal and Household Hygiene Behaviour: A Multi-Country Study (2016) (32)
Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection (2007) (31)
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. (2005) (31)
PASSAGE OF INFLUENZA STRAINS IN THE PRESENCE OF AMINOADAMANTANE (1970) (30)
Simian Virus 40-Induced T and Tumor Antigens (1969) (30)
Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination (2013) (30)
The interaction of influenza virus haemagglutinin with phospholipid vesicles - morphological and immunological studies. (1981) (29)
Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge (2014) (29)
Targeting influenza virus neuraminidase—a new strategy for antiviral therapy (1998) (29)
Oseltamivir in the management of influenza (2005) (28)
Sequence analysis of the equine H7 influenza virus haemagglutinin gene. (1992) (28)
Human genetics and responses to influenza vaccination: clinical implications. (2004) (28)
Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. (1978) (28)
Immunofluorescent studies on the inhibition of influenza A and B viruses in mammalian cell cultures by amines and ammonium compounds. (1968) (27)
IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination. (1995) (27)
Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself. (2018) (27)
The role of humoral immunity in host defence against influenza A infection in mice (1976) (26)
Initial in vitro screening of drug candidates for their potential antiviral activities (1996) (26)
In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases. (1988) (26)
Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: Antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response (1991) (25)
New Millennium Antivirals against Pandemic and Epidemic Influenza: The Neuraminidase Inhibitors (2002) (25)
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection (2016) (25)
Preparing for the next influenza pandemic. (2000) (24)
Specific inhibitors of influenza virus replication as potential chemoprophylactic agents. (1975) (24)
Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates. (1986) (24)
A host cell selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers (1988) (24)
Antivirus antibodies in myasthenia gravis (1985) (24)
A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine. (1995) (24)
Specific tumour antigen induced by chick embryo lethal orphan (CELO) virus. (1969) (23)
An inhibitor of the particle-associated RNA-dependent RNA polymerase of influenza A and B viruses. (1973) (23)
Human Genetics and Responses to Influenza Vaccination (2004) (23)
In-Vitro Virucidal and Virustatic anti HIV-1 Effects of Extracts from Persea Americana Mill, (Avocado) Leaves (1996) (23)
A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community (2004) (23)
Trial of ribavirin for the treatment of HBsAg positive chronic liver disease. (1978) (23)
Human Virology: A Text for Students of Medicine, Dentistry and Microbiology (1993) (22)
Preparing for the first influenza pandemic of the 21st century (2005) (22)
A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus (2003) (22)
Intratypic electrophoretic variation of structural and non-structural polypeptides of human influenza A viruses. (1981) (22)
Early interactions between animal viruses and the host cell: relevance to viral vaccines (1986) (21)
Polypeptide Composition of Influenza B Viruses and Enzymes Associated with the Purified Virus Particles (1973) (21)
Understanding the Impact of Resistance to Influenza Antivirals (2021) (20)
Biochemical and serological studies of influenza B viruses: comparisons of historical and recent isolates. (1984) (20)
Sequence analysis of an HIV‐1 isolate which displays unusually high‐level AZT resistance in vitro (1992) (20)
An investigation of antigenic drift of neuraminidases of influenza A (H1N1) viruses (1984) (20)
Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions. (1984) (19)
The Great Influenza: The Epic Story of the Deadliest Plague in History (2004) (19)
Transplantation immunity following immunization with extracts of adenovirus 12 tumour cells (1970) (19)
INFLUENZA RNA TRANSCRIPTASE INHIBITORS: STUDIES IN VITRO AND IN VIVO (1977) (19)
The growth of rubella virus in small laboratory animals. (1967) (19)
Preclinical In Vitro Activity of QR-435 Against Influenza A Virus as a Virucide and in Paper Masks for Prevention of Viral Transmission (2007) (19)
The haemagglutinins of influenza A (H1N1) viruses in the ‘O’ or ‘D’ phases exhibit biological and antigenic differences (1993) (19)
Antibiotic resistance – a call to arms for primary healthcare providers (2013) (19)
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing (2013) (18)
Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR. (1987) (18)
An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses. (1995) (17)
Aminoadamantane-resistant strains of influenza A2 virus (1973) (17)
Immunity to influenza. (1975) (17)
Immunological relationships of some oncogenic DNA viruses. I. Transplantation immunity studies. (1969) (17)
A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attentuated in virulence for volunteers (2005) (16)
Inactivation of influenza and other viruses by a mixture of virucidal compounds. (1971) (16)
Assessment of human influenza pandemic scenarios in Europe. (2015) (16)
Flu: Effect of Vaccine in Elderly Care Home Residents: A Randomized Trial (2007) (16)
Antiviral activity of ribavirin on influenza infection in ferrets. (1975) (14)
Factors influencing inappropriate antibiotic prescription in Europe (2013) (14)
In Vivo Prophylactic Activity of QR-435 Against H3N2 Influenza Virus Infection (2007) (14)
Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine. (2003) (14)
More action, less resistance: report of the 2014 summit of the Global Respiratory Infection Partnership (2015) (14)
Rapid immune response to influenza vaccination (1993) (14)
The use of monoclonal antibodies in virology (1982) (13)
Influenza A (H3N2) component of recommended vaccine induces antibody to current virus (1990) (13)
Rapid antibody response to influenza vaccination in "at risk" groups. (2000) (13)
Small virus‐like particles bud from the cell membranes of normal as well as HIV‐infected human lymphoid cells (1993) (13)
A designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu). (2003) (13)
Immunofluorescence studies of T and virus capsid antigens induced by chick embryo lethal orphan virus. (1970) (13)
Replication of influenza A and B viruses in human diploid cells. (1983) (13)
Chick embryo lethal orphan (CELO) virus as a possible contaminant of egg-grown virus vaccines (1969) (12)
An antigenic analysis using monoclonal antibodies of influenza A (H3N2) viruses isolated from an epidemic in a semi-closed community. (1986) (12)
Growth of rubella virus in the hamster (Mesocricetus auratus). (1966) (12)
HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens. (1997) (12)
Challenges and strategies for AIDS vaccine development. (1993) (12)
New Antiviral Drugs, Vaccines and Classic Public Health Interventions against SARS Coronavirus (2005) (11)
PROTECTIVE EFFECT OF AWINOADAWANTANE ON INFLUENZA A2 INFECTIONS IN THE FAMILY ENVIRONMENT (1970) (11)
Inhibition of Tumour Formation with Adenovirus 12 Tumour Cells in Hamsters immunized with Various Adenoviruses (1967) (11)
Problems of antiviral therapy (1983) (11)
Modulation of human natural killer cytotoxicity by influenza virus and its subunit protein. (1984) (11)
Properties of transplantation antigen present in cell-free extracts of adenovirus-12 tumours. (1972) (11)
Potential target sites for antiviral inhibitors of human immunodeficiency virus (HIV). (1989) (11)
Conquest of viral diseases: a topical review of drugs and vaccines. (1985) (11)
How HIV-1 lentivirus causes immune deficiency disease. (1999) (11)
An immunologic marker technique for the Cendehill vaccine strain of rubella virus. (1970) (10)
Molecular aspects of AZT resistance in HIV1. (1992) (10)
Inhibition of the growth of influenza and rubella viruses by amines and ammonium salts. (1967) (10)
Infection of cultured human muscle cells by influenza virus. (1985) (10)
Early herald wave outbreaks of influenza in 1916 prior to the pandemic of 1918 (2001) (10)
Effects of 1-beta-D-ribofuranosyl 1, 2, 4-triazole-3-carboxamide on influenza virus replication and polypeptide synthesis. (1975) (10)
Evidence of diffusion artefacts in diaminobenzidine immunocytochemistry revealed during immune electron microscope studies of the early interactions between influenza virus and cells. (1982) (10)
Changes accompanying long term tissue culture of an adenovirus type 12 tumour cell line. (1968) (9)
Would you volunteer to be quarantined and infected with influenza virus? (2005) (9)
Modification of pH Conferring Virucidal Activity on Dental Alginates (2015) (9)
Inhibition of herpes virus by a new compound--acyclic guanosine. (1979) (9)
Analysis of antigenic determinants on internal and external proteins of influenza virus and identification of antigenic subpopulations of virions in recent field isolates using monoclonal antibodies and immunogold labelling (2005) (9)
Influenza is now a preventable disease (2006) (9)
Sodium Deoxycholate Exerts a Direct Destructive Effect on HIV and Influenza Viruses in vitro and Inhibits Retrovirus-Induced Pathology in An Animal Model (1994) (8)
Persistent rubella virus infection in hamster lung cells. (1969) (8)
Chapter 15 Orthomyxoviridae (1987) (8)
Clinical, scientific and ethnographic studies of influenza in quarantine (2012) (8)
Chick embryo lethal orphan (CELO) virus: some physical and immunological properties. (1971) (8)
Inhibition of swine influenza virus A/New Jersey/76 (Hsw1N1) multiplication and polypeptide synthesis by amantadine (1977) (8)
FluINsure™, an inactivated trivalent influenza vaccine for intranasal administration, is protective in human challenge with A/Panama/2007/99 (H3N2) virus (2004) (8)
A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic. (1971) (8)
Influenza — The Chameleon Virus (2003) (8)
Construction and characterization of a full-length HIV-1(92UG001) subtype D infectious molecular clone. (2002) (8)
Quantification of influenza virus structural proteins using rocket immunoelectrophoresis. (1978) (8)
Sequence analysis of proviral HIV RT amplified directly by a semi‐quantitative technique from AZT treated patients (1994) (8)
Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts (2010) (8)
Drug resistance in viruses, other microbes and eukaryotes. (1987) (8)
In vitro inhibition of rubella virus by 1-adamantanamine hydrochloride (2005) (7)
Failure of influenza vaccine to prevent two successive outbreaks of influenza A H1N1 in a school community. (1990) (7)
Studies on the antibody response of mice and humans after immunization with potential influenza virus A (H1N1) vaccines (1993) (7)
Molecular and Biological Aspects of AZT Resistant Viruses Derived from HIV-1 Infected Individuals (1993) (7)
The end of the beginning: vaccines for the next 25 years. (2008) (7)
In vitro anti-HIV-1 virucidal activity of tyrosine-conjugated tri- and dihydroxy bile salt derivatives. (2000) (7)
Attenuation of virulence in influenza B viral infection of volunteers. (1994) (7)
Nature's biological weapon (2004) (6)
In vitro correlation between human leukocyte antigen class I and II phenotype and HIV infectivity of activated peripheral blood mononuclear cell cultures. (1998) (6)
Amantadine for influenza A. (1991) (6)
Changes in the antibody status of a population following epidemic infection by influenza virus A2/Hong Kong/1/68 (1970) (6)
Controlling pandemic flu (2013) (6)
Influenza Vaccines Have a Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic (2010) (6)
Immunological studies with the HA1 and HA2 polypeptides of influenza A virus haemagglutinin. (1978) (6)
A comparison of adenovirus 12 induced T and tumour antigens by rate-zonal centrifugation. (1970) (6)
Determination of the Type of Nucleic Acid in Rubella Virus using 5-Bromo-2′-deoxyuridine (1965) (6)
Functional and antigenic analyses of the 1918 influenza virus haemagglutinin using a recombinant vaccinia virus expression system. (2006) (6)
Analysis of resistance mutants of viral polymerases. (1996) (6)
Electrophoretic analysis of nucleic acids isolated from scrapie-infected hamster brain. (1996) (6)
Inhibitors of influenza virus replication. (1979) (6)
Activity of influenza vaccine against virus strains now circulating (1992) (6)
Differences in the electrophoretic migration rates of polypeptides and RNAs of recent isolates of influenza B viruses (2005) (5)
Chemotherapy and control of influenza (1975) (5)
Detection of antigenic variation of influenza A matrix protein by a competitive radioimmunoassay. (1981) (5)
Biochemical and antigenic analysis using monoclonal antibodies of a series of of influenza A (H3N2) and (H1N1) virus reassortants. (1986) (5)
Protein and nucleic acid analysis of influenza B viruses isolated in Italy in 1984 (1989) (5)
Drugs to combat the epidemic and pandemic faces of influenza (2002) (5)
Lack of evidence for complete resistance of peripheral blood mononuclear cells to HIV-1 and HIV-2 infection. (2008) (5)
AIDS and AIDS-related infections: current strategies for prevention and therapy. Based on a meeting of the British Society for Antimicrobial Chemotherapy. Stratford-on-Avon, 21-22 April 1988. (1989) (5)
The Holy Grail of influenza virologists (1999) (5)
Natural and 'in vitro' selected antigenic variants of influenza A virus (H2N2). (1998) (4)
Anti Influenza Virus Activity of Amantadine, Rimantadine and Analogues (1984) (4)
The potential of phosphonoformate for the treatment of herpex simplex labialis. (1980) (4)
Construction and biological characterization of an infectious molecular clone of HIV type 1GB8. (2000) (4)
On the trail of a killer (2003) (4)
Electrophoretic migration rate differences of polypeptides of human influenza A viruses: Partial analysis of the genome of influenza vaccine recombinant viruses (2005) (4)
The immunology and epidemiology of influenza virus. (1975) (4)
Direct sequence determination of the influenza B HA-1 gene after PCR amplification of clinical specimens from an infected volunteer. (1993) (4)
The assay of influenza virus structural antigens in vaccines by rocket immunoelectrophoresis. (1977) (4)
Comprar Human Virology | Paul Kellam | 9780199570881 | Oxford University Press (2011) (4)
Isolation of influenza A(H3N2) virus with "O"-->"D" phase variation. (1997) (4)
Chemotherapy of herpes simplex virus infections (1977) (4)
Development of a Human Experimental Infection Model of Respiratory Syncytial Virus (RSV) and Evaluation of an RNA Interference (RNAi) Therapeutic for Safety and Anti-Viral Efficacy in Man (2008) (4)
Concurrent antigenic analysis of recent epidemic influenza A and B viruses and quantitation of antibodies in population serosurveys in Italy (1993) (4)
Approaches towards rational antiviral chemotherapy. (1979) (4)
Zanamivir (Glaxo Wellcome). (2000) (4)
Drug resistance and antiviral agents. (1976) (4)
Immunogold Electron Microscopy Recognizes Prion Protein‐Associated Particles Prepared from Scrapie‐Infected Mouse Brain (2004) (4)
What is the true nature of epidemic influenza virus and how do new epidemic viruses spread? (1987) (4)
Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro (1984) (3)
A difference in the buoyant density of haemagglutinin from rubella virus strains. (1969) (3)
Epidemic and pandemic influenza, who cares and how? (2006) (3)
The Threat of Avian Influenza H5N1: ‘Do We Have the Tools for the Job?’ (2007) (3)
The effect of rubella and herpesvirus homonis on the pre- and post-implantation stages of pregnancy in laboratory animals. (1968) (3)
A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian (2019) (3)
Influenza A: a threatening virus with two faces. (2002) (3)
AIDS vaccine development: let a thousand flowers bloom. (1998) (3)
An international survey of bacterial contamination and householders’ knowledge, attitudes and perceptions of hygiene (2013) (3)
Modeling HIV Concentration During Acute AIDS Infection (1996) (3)
Chemoprophylaxis and Virus Infections of the Respiratory Tract (2017) (3)
Influenza Virology: Current TopicsY. Kawaoka, Ed. Caister Academic Press, Wymondham, UK, 2006.ISBN 1-904455-06-9. £130, 368 pp. (2006) (2)
Antiviral chemotherapy and interferon. (1985) (2)
The Molecular Virology and Epidemiology of Influenza, C.H. Stuart-Harris, C.W. Potter (Eds.). Academic Press, Oxford (1984), 301 (1986) (2)
EFFECT OF RIBAVIRIN ON INFLUENZA VIRUS INFECTION IN FERRETS (1976) (2)
Acetylated galactosamine is a receptor for the influenza C virus glycoprotein (2005) (2)
Cost-effectiveness of public health interventions against human influenza pandemics in France: a methodological contribution from the FLURESP European Commission project. (2019) (2)
Biochemical techniques for the genetic and phenotypic analysis of viruses: ‘Molecular Epidemiology’ (1985) (2)
Induction of protective T cell immunity against influenza using a novel peptide vaccine (2012) (2)
New scientific developments towards an AIDS vaccine: report on a workshop organized by EU programme EVA entitled Novel approaches to AIDS vaccine development held at the Institut Pasteur, Paris. 16-17 November 1995. (1996) (2)
Influenza vaccines have a short but illustrious history (2008) (2)
New laboratory and clinical aspects of antiviral compounds. Introduction: a virological prescript. (1984) (1)
Plaquing characteristics of influenza A virus recombinants of defined genetic composition (2005) (1)
Basic influenza virology and immunology. (2009) (1)
Immimological relationships of some oncogenic DNA viruses (1969) (1)
Inactivation of Influenza and Other Viruses by a Mixture of Virucidal Compounds (1971) (1)
Chemotherapy of Influenza and Herpes Virus Infections (1981) (1)
4-Quinolones do not inhibit the nickase activity of HIV integrase (1991) (1)
Antiviral Drugs (2020) (1)
Molecular biology of influenza virus replication and points of action of Inhibitors (1976) (1)
Anti-human immunodeficiency virus activity of a new immunosuppressant drug called stepronin. (1999) (1)
A journey of zoonotic discovery (2012) (1)
Persistent rubella virus infection in laboratory animals (2005) (1)
Immunological relationships of some oncogenic DNA viruses (1969) (1)
Ca2+-sensitive pore-formation by myxoviruses (1985) (1)
Effectiveness of H1N1 vaccination in Scotland, UK. (2012) (1)
Genome and antigenic analysis of influenza A (H3N2) viruses isolated from an epidemic in a closed community of Carmelite nuns (1990) (1)
Interaction of influenza virus haemagglutinin with cell membranes. (1985) (1)
Demonstration of a tumour and transplantation antigen in hamster tumours induced by an avian adenovirus (CELO) (2005) (1)
Invitro response toinfluenza immunisation by peripheral bloodmononuclear cells frompatients withsystemic lupuserythematosus andother autoimmune diseases (2011) (0)
Evaluation of some novel compounds for anti-HIV and anti-influenza activity (1991) (0)
The evaluation of antiviral compounds for rubella virus using organ cultures (2005) (0)
A year in the life of epidemic influenza virus (1988) (0)
The emergence of pandemic influenza A: bioterrorist versus mother nature. (2005) (0)
Origins of recent pandemics and lessons for surveillance (2014) (0)
Studies with virus-induced tumours, immunisation with virus vaccines, immunisation with non-specific vaccines. Abstr. (1967) (0)
Chromosome, transplantation and tumour antigen studies of three virus-induced tumour cell lines (2005) (0)
The next pandemic (2006) (0)
Antigenic and biochemical studies of influenza viruses isolated in defined community epidemics have allowed the development of a new experimental inactivated vaccine. (1991) (0)
Specific Inhibitors of Influenza Related to the Molecular Biology of Virus Replication (2018) (0)
Virus Research: Preface (2004) (0)
Epidemiology of influenza A and B viruses. Use of monoclonal antibodies to analyze viruses from circumscribed epidemics. (1987) (0)
Influenza surveillance. (1991) (0)
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 356 (1416) (2001) (0)
Modern Medicine for Nurses. 2nd ed. (1973) (0)
Genome analysis of influenza B virus strains isolated during epidemics in boarding schools (2005) (0)
Bird Flu: Flu Fatigue (2007) (0)
Lessons learnt from the global outbreak of a Darwinian masterpiece: Virus infuenza A (H1N1) 2009 (2011) (0)
Liposomal influenza vaccine: a viewpoint by John S. Oxford. (1999) (0)
Influenza: Virus, Vaccines and Strategy: Proceedings of a working group on pandemic influenza Rougemont 1976 (1977) (0)
Bandaging. Retention: keeping things in place. (1989) (0)
ECCMID - Tenth Congress. Influenza and bacterial infections. (2000) (0)
Animal Models of Influenza Virus Infection as Applied to the Investigation of Antiviral Compounds (2018) (0)
Subject Index Vol. 46, 1978 (1978) (0)
Antigenic and biochemical heterogeneity of influenza A viruses. (1980) (0)
Control of epidemic influenza virus: aspects of vaccines and antiviral compounds (1984) (0)
Conservation of H3N2 influenza viruses in pigs: Antigenic and genomic analysis (1988) (0)
Pre-existing immunity in human challenge studies of influenza transmission Reply (2012) (0)
Vaccines from the Spanish Influenza as a firm foundation for new developments (2020) (0)
New biochemical and clinical approaches to the control of epidemic influenza virus? (1982) (0)
Inactivation ofInfluenza andOtherViruses bya Mixture ofVirucidal Compounds (1971) (0)
Pre-existing immunity in human challenge studies of influenza transmission – Authors' reply (2012) (0)
Specific Antiviral Therapy of Respiratory Viruses (1996) (0)
Burnet's O-D phase variation of recent influenza a (H1N1) viruses: An antigenic analysis using monoclonal and polyclonal antibodies to HA (1988) (0)
A view from the virology research laboratory (2017) (0)
A curious thing (2008) (0)
Quo vadis antiviral agents for herpes, influenza and HIV? (1995) (0)
Molecular epidemiology of influenza virus: antigenic and biochemical analysis of influenza virus outbreaks in schools. (1985) (0)
Contents, Vol. 46, 1978 (1978) (0)
A Perspective of Influenza Pandemics (2014) (0)
The current threat of avian influenza A is real and not a mirage. (2007) (0)
Control of herpes virus infections by drugs or vaccines? (1977) (0)
Running Title: Live virus challenge trial of T cell influenza vaccine 4 (2015) (0)

This paper list is powered by the following services:

Other Resources About John Oxford

en.wikipedia.org

What Schools Are Affiliated With John Oxford?

John Oxford is affiliated with the following schools:

John Oxford's Academic­Influence.com Rankings